About the Tecnimede Group
It was with an eye to the future that, in 1980, the Tecnimede Group was established, a pharmaceutical company 100% funded by Portuguese private capital.
Product Development
We manage over 4000 MAs globally and have developed over 130 products that are marketed worldwide.
Business Development
In-Licensing and Out-Licensing are part of our strategic axis with a view to strengthening the portfolio of all our subsidiaries, business areas, and areas of expertise.
Production
Our manufacturing operations are supported by two production centres of excellence, Atlantic Pharma and Atlas Pharm, which are committed to innovation and quality.
Commercial partnerships
We are continuously exploring new strategic partnerships that deliver innovative healthcare products with the highest quality standards.
Partnerships
Our partnerships, which extend across most of Europe, Africa, Asia, the Middle East, Oceania, and North and South America, allow us to grow both locally and globally.
Our Mission Statement
Our mission is to improve and preserve human life and health through the development, production, and distribution of pharmaceutical products, with a strong focus on quality and technological innovation.
Our Products
Our activities cover the entire pharmaceutical life cycle: Research, Development, Production, and Distribution. We introduce pharmaceutical products to the market, which are designed to treat the most prevalent illnesses. Particular attention is given to cardiovascular and metabolic disorders, degenerative diseases of the nervous system, and infectious diseases.
Projetos em curso
Conheça alguns dos projetos em curso de I&D do Grupo Tecnimede.